References - - BioPharm International

ADVERTISEMENT

References


BioPharm International


BOOKSAhern TJ, Manning M, eds. Stability of protein pharmaceuticals, part A: chemical and physical pathways of protein degradation. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Ahern TJ, Manning M, eds. Stability of protein pharmaceuticals, part B: in vivo pathways of degradation and strategies for protein stabilization. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Avis KE, Wu VL. Biotechnology and biopharmaceutical manufacturing, processing, and preservation. Drug manufacturing technology series, volume 2. Buffalo Grove (IL):Interpharm Press; 1996.

Banga AK. Electrically assisted transdermal and topical drug delivery. London: Taylor & Francis; 1998.

Bontempo J, ed. Development of biopharmaceutical parenteral dosage forms. New York: Marcel Dekker; 1997.

Carpenter, JF, Chang BS, Garzon-Rodriguez W, Randolph TW. Rational design of stabilized lyophilized protein formulations: theory and practice. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: theory and practice. New York: Kluwer/Plenum Press; 2002. p. 109-133.

DeSain C. Documentation basics that support good manufacturing practices. Cleveland (OH): Advanstar Communications; 1993.

Hider RC, Barlow D. Polypeptide and protein drugs: production, characterization, and formulation. Ellis Horwood Ltd: Chichester UK; 1991.

Huxsoll JF. Quality assurance for biopharmaceuticals. New York: John Wiley & Sons; 1994.

Kibbe AH, ed. Handbook of pharmaceutical excipients. Third Ed. Washington, DC: American Pharmaceutical Association; 2000.

McNally EJ, ed. Protein formulation and delivery. New York: Marcel Dekker; 2000.

Rowe RC, Roberts RJ. Intelligent software for product formulation. London: Taylor & Francis; 1998.

Saeb-Parsy K, et al., eds. Instant pharmacology. New York: John Wiley & Sons; 1999.

Wang YJ, Pearlman R, eds. Stability and characterization of protein and peptide drugs: case histories. Pharmaceutical biotechnology series, volume 5. New York: Plenum Press; 1993.

Wang YJ, Pearlman R, eds. Formulation, characterization, and stability of protein drugs: case histories. Pharmaceutical biotechnology series, volume 9. New York: Plenum Press; 1996.


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here